Literature DB >> 8282791

Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

D S Ng1, L A Leiter, C Vezina, P W Connelly, R A Hegele.   

Abstract

We report a Canadian kindred with a novel mutation in the apolipoprotein (apo) A-I gene causing analphalipoproteinemia. The 34-yr-old proband, product of a consanguineous marriage, had bilateral retinopathy, bilateral cataracts, spinocerebellar ataxia, and tendon xanthomata. High density lipoprotein cholesterol (HDL-C) was < 0.1 mM and apoA-I was undetectable. Genomic DNA sequencing of the proband's apoA-I gene identified a nonsense mutation at codon [-2], which we designate as Q[-2]X. This mutation causes a loss of endonuclease digestion sites for both BbvI and Fnu4HI. Genotyping identified four additional homozygotes, four heterozygotes, and two unaffected subjects among the first-degree relatives. Q[-2]X homozygosity causes a selective failure to produce any portion of mature apoA-I, resulting in very low plasma level of HDL. Heterozygosity results in approximately half-normal apoA-I and HDL. Gradient gel electrophoresis and differential electroimmunodiffusion assay revealed that the HDL particles of the homozygotes had peak Stokes diameter of 7.9 nm and contained apoA-II without apoA-I (Lp-AII). Heterozygotes had an additional fraction of HDL3-like particles. Two of the proband's affected sisters had documented premature coronary heart disease. This kindred, the third reported apoA-I gene mutation causing isolated complete apoA-I deficiency, appears to be at significantly increased risk for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282791      PMCID: PMC293756          DOI: 10.1172/JCI116949

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Determination of plasma lipid profiles by automated gas chromatography and computerized data analysis.

Authors:  A Kuksis; J J Myher; L Marai; K Geher
Journal:  J Chromatogr Sci       Date:  1975-09       Impact factor: 1.618

2.  Deficiency of apolipoproteins A-I and C-III and severe coronary heart disease.

Authors:  Y Hiasa; T Maeda; H Mori
Journal:  Clin Cardiol       Date:  1986-07       Impact factor: 2.882

3.  Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II.

Authors:  M C Cheung; J J Albers
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

4.  Agarose gel electrophoresis of plasma lipoproteins using the Durrum cell.

Authors:  G F Maguire; W C Breckenridge
Journal:  Clin Biochem       Date:  1975-06       Impact factor: 3.281

5.  Isolation and characterization of the human apolipoprotein A-I gene.

Authors:  S K Karathanasis; V I Zannis; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Structure of apolipoprotein C-IIToronto, a nonfunctional human apolipoprotein.

Authors:  P W Connelly; G F Maguire; T Hofmann; J A Little
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease.

Authors:  R A Norum; J B Lakier; S Goldstein; A Angel; R B Goldberg; W D Block; D K Noffze; P J Dolphin; J Edelglass; D D Bogorad; P Alaupovic
Journal:  N Engl J Med       Date:  1982-06-24       Impact factor: 91.245

8.  Gene structure of human apolipoprotein A1.

Authors:  C C Shoulders; A R Kornblihtt; B S Munro; F E Baralle
Journal:  Nucleic Acids Res       Date:  1983-05-11       Impact factor: 16.971

9.  Familial apolipoprotein A-I and C-III deficiency, variant II.

Authors:  E J Schaefer; J M Ordovas; S W Law; G Ghiselli; M L Kashyap; L S Srivastava; W H Heaton; J J Albers; W E Connor; F T Lindgren
Journal:  J Lipid Res       Date:  1985-09       Impact factor: 5.922

10.  Quantification of human serum apolipoprotein AI by enzyme immunoassay.

Authors:  J Bury; M Rosseneu
Journal:  Clin Chem       Date:  1985-02       Impact factor: 8.327

View more
  20 in total

Review 1.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.

Authors:  J C Cohen; Z Wang; S M Grundy; M R Stoesz; R Guerra
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

3.  Detection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methods.

Authors:  Phanichand Kodali; Karnakar R Chitta; Julio A Landero Figueroa; Joseph A Caruso; Opeolu Adeoye
Journal:  Metallomics       Date:  2012-09-14       Impact factor: 4.526

4.  Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice.

Authors:  Sean A Wiltshire; Eduardo Diez; Qianqian Miao; Marie-Pierre Dubé; Mireille Gagné; Olivier Paquette; Ronald G Lafrenière; Momar Ndao; Lawrence W Castellani; Emil Skamene; Silvia M Vidal; Anny Fortin
Journal:  Physiol Genomics       Date:  2012-07-17       Impact factor: 3.107

5.  Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.

Authors:  Fabiana Rached; Raul D Santos; Laurent Camont; Marcio H Miname; Marie Lhomme; Carolane Dauteuille; Sora Lecocq; Carlos V Serrano; M John Chapman; Anatol Kontush
Journal:  J Lipid Res       Date:  2014-10-23       Impact factor: 5.922

Review 6.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

7.  Clinical Implications of Lipid Genetics for Cardiovascular Disease.

Authors:  Alanna Strong; Daniel J Rader
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-10

Review 8.  Human genetics of variation in high-density lipoprotein cholesterol.

Authors:  Atif Qasim; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

Review 9.  The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.

Authors:  Rafael Simó; Marta Villarroel; Lídia Corraliza; Cristina Hernández; Marta Garcia-Ramírez
Journal:  J Biomed Biotechnol       Date:  2010-02-17

Review 10.  Approach to the patient with extremely low HDL-cholesterol.

Authors:  Daniel J Rader; Emil M deGoma
Journal:  J Clin Endocrinol Metab       Date:  2012-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.